The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
when you look at predicting mortality from these blood tests using data that supposedly sort of reflects the general US population then actually an alt that's actually at the higher end or maybe just above the normal reference range is associated with reduced mortality but you do want your ast to be to be low
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
the alt a little higher than the ast might be ideal yeah absolutely and you don't necessarily want them all to be very low unless you're of the Southeast Asian